A United States research study of 13,000 clients revealed Tamoxifen decreased the rate of anticipated cancers from one in 130 to one in 236 – a cut of about 45%. When they stated the drug’s advantages ended up being extremely apparent, the American scientists ended their trial early. Other research studies discovered that tamoxifen AND …